11th Vaccines Research and Development: All Things Considered
EARLY BIRD DISCOUNT! Register by May 9, 2014 to receive 20% off your registration!
Register 2, and the 3rd goes FREE with the coupon code RCDVB!

Overview | Speakers | Agenda | Poster Submissions | Venue | Sponsors
Dear Colleague,

GTC is proud to present its 12th Vaccines Research & Development: All Things Considered Conference, to be held in Boston, MA on July 9-11, 2014. This conference continues a tradition of presenting valuable updates and exposure to all aspects of vaccine development in a comfortable, interactive and friendly setting. It brings together the leaders in vaccinology from industry, academia, and the government to examine vaccine development from basic research to marketing.

We bring together the people who make the discoveries, make the decisions, fund the work and license the vaccines and foster their interaction with the attendees to share their perspectives of the vaccine industry.

The 12th Vaccines Research & Development: All Things Considered conference is part of our Infectious Diseases World Summit 2014 and will be held concurrently with two other tracks which are:

3rd Influenza Research & Development
11th Anti-Infectives Partnering and Deal-Making

We look forward to seeing you in Boston!

Best regards,

The 2014 Advisory Committee
 

GOLD SPONSORS
 
2014 SCIENTIFIC ADVISORY BOARD
Alan Barrett
University of Texas

Philip Dormitzer
Novartis


Jay Evans
GlaxoSmithKline


Joseph Joyce
Merck


Josef Kallen
Curevac


Rino Rappuoli
Novartis


Ken Rosenthal
Formerly NEOMED


Connie Schmaljohn
U.S. Army Medical Research Institute of Infectious Diseases


Angela Shen
United States Agency for International Development


Jeffrey Ulmer
Novartis


David Weiner
University of Pennsylvania


Dan Zimmerman
CEL-SCI


What past delegates said about the event:

"It was excellent to see Global Health as a featured tract at the GTCbio Conference this year. The meeting was an outstanding opportunity to review many of the most current technology platforms and product development initiatives being used to address many of the infectious diseases that impact the developing countries the most . It was also a welcome opportunity to spend time with many of the industry, government and NGO stakeholders committed this important area of healthcare."
- Kim Bush, Director, Life Sciences Partnerships, Global Health Program, Bill & Melinda Gates Foundation

“The GTC 11th Vaccines Research and Development: All Things Considered conference was both an informative and highly interactive providing updates on the latest vaccine technologies and information on the status of new or improved vaccines.” 
- Jay t. Evans, Ph.D., Senior Scientist, GSK Vaccines.






 

Attend ALL GTC Conferences for One Year for only $3995 ($1990 for acad/govt)
Click here to sign up!